title: [Anesthetic malignant hyperthermia: what's new in 2012?].
abstract: Malignant hyperthermia (MH) is a pharmacogenetic disorder of anesthesia. Recent advances dealing with epidemiology of MH and the safe anesthetic course of MH susceptible patients are shortly presented here with a special insight into the preparation of modern anesthesia workstations, which they will share in operating room.
authors.affiliation: Département d'anesthésiologie et réanimation, hôpital Robert-Debré, AP-HP, 48, boulevard Sérurier, 75019 Paris, France. ynivoche.debre@invivo.edu
authors.forename: Y
authors.initials: Y
authors.lastname: Nivoche
authors.forename: B
authors.initials: B
authors.lastname: Bruneau
authors.forename: S
authors.initials: S
authors.lastname: Dahmani
mesh_terms: D000758:Anesthesia / Q000009:adverse effects*; D004632:Emergency Medical Services; D020022:Genetic Predisposition to Disease; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D009873:Operating Rooms / Q000458:organization & administration